Bionevia Pharmaceuticals, Inc.
Records under this name other than the patents Bionevia Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 5 of 5 · Back to Bionevia Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,697,735 | Solid forms of epalrestat Lapsed on the fee record Ended Apr 15, 2026 · USPTO record | Lapsed on the fee record | Ended Apr 15, 2026 | USPTO record |
| US 9,611,234 | Choline cocrystal of epalrestat Lapsed on the fee record Ended Apr 4, 2025 · USPTO record | Lapsed on the fee record | Ended Apr 4, 2025 | USPTO record |
| US 9,566,269 | Modified release compositions of epalrestat or a derivative thereof and methods for using the same Lapsed on the fee record Ended Feb 14, 2025 · USPTO record | Lapsed on the fee record | Ended Feb 14, 2025 | USPTO record |
| US 9,447,056 | Solid forms of epalrestat Lapsed on the fee record Ended Sep 20, 2024 · USPTO record | Lapsed on the fee record | Ended Sep 20, 2024 | USPTO record |
| US 10,464,912 | Choline cocrystal of epalrestat Lapsed on the fee record Ended Nov 5, 2023 · USPTO record | Lapsed on the fee record | Ended Nov 5, 2023 | USPTO record |